|
Effects of HIIT vs. TRE on Type 2 Diabetes Risk
RECRUITINGN/ASponsored by Syracuse University
Actively Recruiting
PhaseN/A
SponsorSyracuse University
Started2024-03-15
Est. completion2025-09-30
Eligibility
Age14 Years – 30 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07215533
Summary
The primary aim of this randomized controlled trial is to examine the effects of a 4-week high-intensity interval training (HIIT) and time-restricted eating (TRE) intervention on cardiometabolic biomarkers in adolescents and young adults.
Eligibility
Age: 14 Years – 30 YearsHealthy volunteers accepted
Inclusion Criteria: * Adolescents (age 14-17 years old with sex- and race-specific BMI percentile ≥85th) and young adults with overweight and obesity (age 18 to 30 years old with BMI ≥25 kg/m2) Exclusion Criteria: * Chronic medical conditions: heart disease, arrhythmias, diabetes, thyroid disease, bleeding disorder, history of pulmonary disease, hypertension, hepatorenal disease, musculoskeletal disorder, neuromuscular/neurological disease, autoimmune disease, cancer, peptic ulcers, anemia, or chronic infection (HIV). * Have taken any heart, pulmonary, thyroid, anti-hyperlipidemic, hypoglycemic, anti- hypertensive, endocrinologic (e.g., thyroid, insulin, etc.), emotional/psychotropic (e.g., Prednisone, Ritalin, Adderall), neuromuscular/neurological, or androgenic medications (anabolic steroids). * Have a pacemaker.
Conditions5
DiabetesHigh-intensity Interval TrainingMetabolic DiseasesObesity and Type 2 DiabetesTime Restricted Eating
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorSyracuse University
Started2024-03-15
Est. completion2025-09-30
Eligibility
Age14 Years – 30 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07215533